Xiaozhang Xu
Overview
Explore the profile of Xiaozhang Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang Y, Qiao L, Qian Q, Zhang R, Li Y, Xu X, et al.
Oncogene
. 2025 Mar;
PMID: 40055567
Regulatory T cells (Tregs), an immunosuppressive subpopulation of CD4 T cells, are prevalent in tumor tissues, where they impede effective antitumor immune responses and represent potential targets for immunotherapy. However,...
2.
Pan Y, Wei Y, Zhan X, Bu Q, Xu Z, Xu X, et al.
Mediators Inflamm
. 2024 Dec;
2024:8831821.
PMID: 39629085
Hepatic macrophages play an indispensable role in liver pathophysiology, serving as key orchestrators of both liver injury and repair processes. ATG16L1 (autophagy-related 16 like 1) has emerged as a novel...
3.
Zhou J, Gu J, Qian Q, Zhang Y, Huang T, Li X, et al.
J Clin Invest
. 2024 Sep;
134(20).
PMID: 39264847
Current research reports that lactate affects Treg metabolism, although the precise mechanism has only been partially elucidated. In this study, we presented evidence demonstrating that elevated lactate levels enhanced cell...
4.
Dai S, Xu F, Xu X, Huang T, Wang Y, Wang H, et al.
Cancer Cell Int
. 2024 Jul;
24(1):235.
PMID: 38970064
Background: Colorectal cancer is among the most common malignant tumors affecting the gastrointestinal tract. Liver metastases, a complication present in approximately 50% of colorectal cancer patients, are a considerable concern....
5.
Gu J, Xu X, Li X, Yue L, Zhu X, Chen Q, et al.
Oncogene
. 2024 Jun;
43(31):2389-2404.
PMID: 38890429
The role of tumor-resident microbiota in modulating tumor immunity remains unclear. Here, we discovered an abundance of intra-tumoral bacteria, such us E.coli, residing and resulting in Colorectal cancer liver metastasis...
6.
Yue L, Xu X, Dai S, Xu F, Zhao W, Gu J, et al.
Sci Rep
. 2023 Aug;
13(1):14092.
PMID: 37640741
Approximately 25-30% of those affected by colorectal cancer (CRC), the most prevalent gastrointestinal malignancy, develop metastases. The survival rate of patients with liver metastasis of CRC (CRLM) remains low owing...
7.
Zhou J, Shao Q, Lu Y, Li Y, Xu Z, Zhou B, et al.
Front Oncol
. 2022 Aug;
12:960066.
PMID: 35965549
Background: Programmed cell death-1 (PD-1) immune checkpoint inhibitors are not effective in treating all patients with hepatocellular carcinoma (HCC), and regulatory T cells (Tregs) may determine the resistance to anti-PD-1...
8.
Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, et al.
Cell Rep
. 2022 Jul;
40(3):111122.
PMID: 35858574
No abstract available.
9.
Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, et al.
Cell Rep
. 2022 Jun;
39(12):110986.
PMID: 35732125
Regulatory T (Treg) cells play a vital role in maintaining the immunosuppressive tumor microenvironment. Lactate is a crucial metabolite in cancer and is related to tumor prognosis, metastasis, and overall...